Johns Hopkins researchers discovered that a drug commonly used to treat toenail fungus also can block angiogenesis, the growth of new blood vessels commonly seen in cancers.
The drug, itraconazole, is FDA approved for human use, which may fast-track its availability as an anti-cancer drug.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.